Orchestra BioMed Holdings (OBIO) Other Working Capital Changes (2022 - 2025)
Orchestra BioMed Holdings (OBIO) posted quarterly Other Working Capital Changes of -$172000.0 for Q1 2026, up 76.5% year-over-year from -$97448.9 in Q1 2025, and down 19.44% quarter-over-quarter from -$144000.0 in Q4 2025.
Powered by 
Analysis
Orchestra BioMed Holdings (OBIO) Other Working Capital Changes (2022 - 2025) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has reported Other Working Capital Changes for 5 consecutive years, with -$172000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 76.5% year-over-year to -$172000.0; the TTM figure through Mar 2026 stood at $10000.0 (up 101.13% YoY), while the FY2025 annual figure was -$550000.0, up 15.64% from the prior year.
- Other Working Capital Changes slipped to -$172000.0 in Q1 2026 per OBIO's latest filing, from -$144000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.5 million in Q1 2023 and bottomed at -$774000.0 in Q2 2023.
- Historically, Other Working Capital Changes has averaged $111058.8 across 5 years, with a median of -$35000.0 in 2025.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes tumbled 1192.68% — and 2024, when it surged 180.25%.
- Orchestra BioMed Holdings' Other Working Capital Changes stood at -$123000.0 in 2022, then sank by 1192.68% to -$1.6 million in 2023, then soared by 180.25% to $1.3 million in 2024, then slumped by 111.29% to -$144000.0 in 2025, then retreated by 19.44% to -$172000.0 in 2026.
- Business Quant data shows OBIO's Other Working Capital Changes at -$172000.0 in Q1 2026, -$144000.0 in Q4 2025, and $993000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Orchestra BioMed Holdings | 322.25 Mn | 127.72 Mn | 63,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -13.31 Mn |
| Dec 31, 2025 | -13.31 Mn |
| Sep 30, 2025 | -721,000.00 |
| Sep 30, 2025 | -721,000.00 |
| Jun 30, 2025 | -667,000.00 |
| Jun 30, 2025 | -667,000.00 |
| Mar 31, 2025 | -732,000.00 |
| Mar 31, 2025 | -732,000.00 |
| Dec 31, 2024 | -77,000.00 |
| Dec 31, 2024 | -77,000.00 |
| Sep 30, 2024 | -803,000.00 |
| Sep 30, 2024 | -803,000.00 |
| Jun 30, 2024 | -628,000.00 |
| Jun 30, 2024 | -628,000.00 |
| Mar 31, 2024 | -497,000.00 |
| Mar 31, 2024 | -497,000.00 |
| Dec 31, 2023 | -88,000.00 |
| Dec 31, 2023 | -88,000.00 |
| Sep 30, 2023 | -271,000.00 |
| Sep 30, 2023 | -271,000.00 |